Quality Investor
MarketsPortfolioEvidenceTestedCompareWatchlistAbout 

Exzeo Group, Inc.

Rank #174HypergrowthWatchlistCompare with other stocks

XZO · NYSE · Financial Services

Exzeo Group, Inc. (XZO) — Rank #174 by gross profitability (GP/assets 0.34) · ROE 28.7% · Piotroski F-Score 5 / 9.

As-of 2026-10-30 · CIK 0001873951 · all metrics point-in-time as of the filing date.

About

Exzeo Group, Inc. provides turnkey insurance technology and operations solutions to insurance carriers and agents in the United States.

Show more

The company offers Exzeo Platform, an Insurance-as-a-Service (IaaS) platform that provides technology-based solutions for operational and administrative activities, such as quoting and underwriting, policy management, claims management, data reporting, and financial reporting; and streamlines and automates interactions between insurance carriers and policyholders. It also provides CasaClue, a data repository; Harmony, a policy administration platform that streamlines the entire policy lifecycle; AtlasViewer, a mapping and data visualization platform that integrates location-based data from multiple sources; and Mercury, a workflow solution designed to ensure uniform routing and policy change tracking. In addition, the company offers ClaimColony, an End-to-end claims management platform; AtlasViewer, a tool to look at claims and manage the claims lifecycle; JustEZ app which helps sync inspections from various carriers, schedule appointments, sync photos to cloud, and write scoping reports; Exahub, a centralized data platform; and ExzeoIQ that provides transparent reporting for customers. The company was formerly known as TypTap Insurance Group, Inc. Exzeo Group, Inc.

was founded in 2012 and is based in Tampa, Florida. Exzeo Group, Inc. is a subsidiary of HCI Group, Inc.

Industry
Insurance - Diversified
Sector
Financial Services
State
FL
Filer Category
Emerging growth company
Fiscal Year End
December 31
Website
exzeo.com

Company Snapshot

P/S is the primary valuation lens — earnings are reinvested, not available for P/E.

Market Cap

—

P/E (annual)

—

P/S (annual)

—

P/B

—

P/OCF (annual)

—

Shareholder Yield

—

Employees

354

Industry

Insurance - Diversified

Exchange

NYSE

11/12

Flags passed

XZO passes 11/12 quality flags

1 caution to review

  • CAUTION
    Dilution above 2%

    Annual share count increase exceeds 2%. May be acceptable for high-growth companies funding talent via stock compensation

  • PASS
    Gross margin holding
  • PASS
    FCF not negative from investment
  • PASS
    Disclosure consistent
  • PASS
    Revenue not declining
  • PASS
    Operating margin holding
  • PASS
    Free cash flow intact
  • PASS
    Passes safety gate
  • PASS
    Balance sheet stable
  • PASS
    No competitive retreat
  • PASS
    SBC not compressing margin
  • PASS
    No valuation convergence

Strengths Revenue growth accelerating · Operating leverage expanding · Deferred revenue growing · Sequential beat (rev + EPS)

A count of the 12 warning flags that could be evaluated. Unweighted: colour follows the worst flag.

Quality Profile

Profitability

1/1 pass
GP / assets
0.34
Return on equity
28.7%
Gross margin trend
PASS

Safety

1/1 pass
Balance-sheet safety
PASS
Debt / equity
0.34
Current ratio
1.85×
Net cash
$136.73M

Cash Flow

3/3 pass
Positive FCF
PASS
Cash-backed earnings
PASS
Accruals healthy
PASS
SBC / revenue
1.2%

Growth

1/2 pass
Revenue growth
62.0%
Piotroski F-Score
5 / 9
Share dilution
3.5%

Revenue growth and the path to profitability (margin trend) are the primary reads at this stage.

Profitability

Does it make money well?

No warning flags · GP/assets 49th percentile of 36 SIC 7372 peers

Gross profitability (GP / assets)

0.34

Primary signal (Novy-Marx).

49th pctl of 36 SIC 7372 peers

Return on equity

28.7%

Gross margin

60.4%

23rd pctl of 36 SIC 7372 peers

Revenue growth (YoY)

62.0%

RPO growth (YoY)

34.0%

Remaining performance obligations growth — RPO > revenue = forward demand building.

Gross margin improving

Margin trend vs prior year.

PASS

Operating Leverage

202320242025
Revenue vs COGS
Revenue vs OpEx
Op. Income vs Revenue

Cash Flow Health

Is the cash real?

No warning flags · FCF 18% above net income

Free cash flow

$97.45M

Operating cash flow minus capex.

Positive free cash flow

PASS

FCF vs net income

17.8%

(FCF − net income) ÷ |net income|. Positive: cash above earnings. Negative: below.

FCF not below net income

Fails when free cash flow is below net income (yellow flag).

PASS

Accruals healthy

Cash-backed earnings.

PASS

SBC / revenue

1.2%

Stock-based comp intensity.

Balance Sheet Strength

Can it survive a storm?

Caution: Dilution above 2% · net cash $136.73M, F-Score 5/9

Balance-sheet safety

Composite anti-fragile check.

PASS

Debt / equity

0.34

77th pctl of 32 SIC 7372 peers (best = lowest)

Current ratio

1.85×

46th pctl of 36 SIC 7372 peers

Quick ratio

1.51×

Net cash

$136.73M

Cash & equivalents minus total debt.

Piotroski F-Score

5 / 9

Fundamental-strength score (0-9).

Valuation

Is the price reasonable?

No warning flags

Capital allocation quality

Composite score

2.3 / 5

Fair
Share count trend
3.5%1/5 Weak
Buyback timing
N/AN/A
Dividend growth consistency(non-payer or broken streak)
0 yr3/5 Good
Net debt trajectory
0.0%3/5 Good

Lifecycle Phase History

20232025
Hypergrowth

Price History

XZO-21.2% · -24.0% CAGRSPY+13.6% · +15.9% CAGR

View full financial statements →

Source filings on SEC EDGAR: 10-K annual reports · 10-Q quarterly reports